BDBM683790 4-(2- {[(2R,7aS)-2- fluoro- hexahydro-1H- pyrrolizin-7a- yl]methoxy}-4- [(1S,6R)-3,9- diazabicyclo[4.2. 1]nonan-3-yl]- 8- fluoroquinazolin- 7- yl)-5- ethylnaphthalen- 2-ol::US20240217982, Example 11-5

SMILES CCc1cccc2cc(N)cc(-c3ccc4c(nc(OC[C@@]56CCCN5C[C@H](F)C6)nc4c3F)N3CC[C@H]4CC[C@@H](C3)N4)c12

InChI Key InChIKey=ZLXYTCRNUGZNDH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 683790   

TargetGTPase KRas [G12D](Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM683790(US20240217982, Example 11-5 | 4-(2- {[(2R,7aS)-2- ...)
Affinity DataIC50: 30nMAssay Description:Recombinant GDP-loaded KRAS G12D (20 nM) was treated with compound at room temperature for 20 minutes in assay buffer (10 mM Hepes pH 7.4, 150 mM NaC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
US Patent